France· FR:69855489
KIVEXA 600 mg/300 mg, comprimé pelliculé
A medicinal product containing lamivudine + abacavir (sulfate d'), registered in France by VIIV HEALTHCARE (PAYS-BAS), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- LAMIVUDINE + ABACAVIR (SULFATE D')
- Manufacturer
- VIIV HEALTHCARE (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400936572843plaquette(s) PVC PVDC aluminium de 30 comprimé(s)EUR 174.24
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lamivudine + abacavir (sulfate d') in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainABACAVIR/LAMIVUDINA ACCORD 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- United KingdomAbacavir 600mg / Lamivudine 300mg tabletsLupin Healthcare (UK) Ltd
- GermanyAbacavir/Lamivudin AlAliud Pharma Gmbh
- FinlandAbacavir/Lamivudin MylanParanova Oy
- NetherlandsAbacavir/Lamivudine Accord 600 mg/300 mg, filmomhulde tablettenAccord Healthcare B.V.
- United StatesAbacavir and LamivudineCipla USA Inc.
- SwedenAbacavir/Lamivudine Accord 600 mg/300 mg Filmdragerad tablettAccord Healthcare B.V.
- CanadaAPO-ABACAVIR-LAMIVUDINEAPOTEX INC
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Abacavir/Lamivudin Ratiopharm, Abacavir/Lamivudin Sandoz
- Belgium · Abacavir/Lamivudine Viatris
- Bulgaria · Abacavir/Lamivudine Viatris, Абакавир/Ламивудин Майлан
- Cyprus · Kivala
- Germany · Abacavir/Lamivudin Al, Abacavir/Lamivudin Aurobindo
- Denmark · Abacavir/Lamivudin Medical Valley, Abacavir/Lamivudin Mylan
- Estonia · Abacavir/Lamivudine Auxilia, Abacavir/Lamivudine Mylan
- Spain · Abacavir/Lamivudina Aurovitas, Abacavir/Lamivudina Dr. Reddys
- Finland · Abacavir/Lamivudin Mylan, Abacavir/Lamivudin Viatris
- United Kingdom (Northern Ireland) · Abacavir/Lamivudin Sandoz, Abacavir/Lamivudine Accord
- Greece · Abacavir+lamivudine Mylan Pharma, Varistren
- Hungary · Abacavir/Lamivudine Teva
- Ireland · Abacavir/Lamivudine Mylan, Abacavir/Lamivudine Viatris
- Iceland · Kivexa
- Italy · Abacavir E Lamivudina Aurobindo, Abacavir E Lamivudina Sun
- Liechtenstein · Kivexa
- Lithuania · Abacavir / Lamivudine Auxilia, Abacavir/Lamivudine Accord
- Luxembourg · Abacavir/Lamivudine Viatris
- Latvia · Abacavir/Lamivudine Accord, Abacavir/Lamivudine Mylan
- Netherlands · Abacavir Sulfate / Lamivudine Aurobindo, Abacavir/Lamivudin Teva
- Norway · Abacavir/Lamivudin Mylan, Abacavir/Lamivudine Viatris
- Poland · Abacavir + Lamivudine Sandoz
- Portugal · Abacavir + Lamivudina Aurovitas, Abacavir + Lamivudina Farmoz
- Romania · Abacavir/Lamivudină, Abacavir/Lamivudină Mylan
- Sweden · Abacavir/Lamivudine Accord, Abacavir/Lamivudine Glenmark
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c361209a-5f75-4e1f-91ec-8e41993efce7 GET /v1/drugs/c361209a-5f75-4e1f-91ec-8e41993efce7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69855489",
"date_amm": "2004-12-17",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/04/298",
"substance": "LAMIVUDINE + ABACAVIR (SULFATE D')",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about lamivudine + abacavir (sulfate d').
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.